Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$455,470
-$121,310 QoQ
Shares Held
1,020
-37.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $91,993,189 across 32 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
9,269,926 | $52,838,578 | |
| 2 | QURE |
uniQure N.V.
|
197,242 | $9,084,966 | |
| 3 | ABVX |
Abivax S.A.
|
51,903 | $6,916,593 | |
| 4 | ABEO |
Abeona Therapeutics Inc.
|
755,021 | $4,666,029 | |
| 5 | ZVRA |
Zevra Therapeutics, Inc.
|
231,465 | $3,319,208 | |
| 6 | UNCY |
Unicycive Therapeutics, Inc.
|
374,132 | $1,754,679 | |
| 7 | ANAB |
Anaptysbio, Inc
|
16,868 | $1,138,590 | |
| 8 | NKTR |
Nektar Therapeutics
|
15,967 | $1,114,656 |
All Filings in VRTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $455,470 | 1,020 | Shares | Defined | 2026-05-15 | |
| 2023-06-30 | $576,780 | 1,639 | Shares | Defined | 2023-08-11 | |
| 2020-06-30 | $1,084,598 | 3,736 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $871,848 | 3,664 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||